Stay updated on RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.

Latest updates to the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study record page now shows a 403 Forbidden error, blocking access to the trial details and related links. The previous content and documents listed on the page are no longer accessible.SummaryDifference22%

- Check37 days agoChange DetectedThe page now includes a new 150 mg dosing arm for Part 2, long-extension/open-label options, IPD sharing documents, and new locations; several Part 1 dose cohorts and placebo arms were removed, reflecting a revised trial structure.SummaryDifference5%

- Check45 days agoChange DetectedFooter revision indicator has been updated from v3.6.5 to v3.6.6, reflecting a software update to the site.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a minor update to the page. No changes to the study details or other visible content are indicated.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the study details page. This suggests a small metadata or formatting adjustment rather than substantive changes to the study content.SummaryDifference0.0%

Stay in the know with updates to RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.